BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36588724)

  • 1. Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis.
    Gao H; Wu J; Sun Z; Zhang F; Shi T; Lu K; Qian D; Yin Z; Zhao Y; Qin J; Xue B
    Front Pharmacol; 2022; 13():1062249. PubMed ID: 36588724
    [No Abstract]   [Full Text] [Related]  

  • 2. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
    Albers JJ; Chen CH; Adolphson JL
    J Lipid Res; 1981 Nov; 22(8):1206-13. PubMed ID: 7320631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
    Tanigawa H; Billheimer JT; Tohyama J; Fuki IV; Ng DS; Rothblat GH; Rader DJ
    Circulation; 2009 Jul; 120(2):160-9. PubMed ID: 19564558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
    Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
    J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
    Holleboom AG; Daniil G; Fu X; Zhang R; Hovingh GK; Schimmel AW; Kastelein JJ; Stroes ES; Witztum JL; Hutten BA; Tsimikas S; Hazen SL; Chroni A; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3066-75. PubMed ID: 23023370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the components of reverse cholesterol transport in lecithin:cholesterol acyltransferase deficiency.
    Park MS; Kudchodkar BJ; Frohlich J; Pritchard H; Lacko AG
    Arch Biochem Biophys; 1987 Nov; 258(2):545-54. PubMed ID: 3674887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin-cholesterol acyltransferase (LCAT) catalyzes transacylation of intact cholesteryl esters. Evidence for the partial reversal of the forward LCAT reaction.
    Sorci-Thomas M; Babiak J; Rudel LL
    J Biol Chem; 1990 Feb; 265(5):2665-70. PubMed ID: 2406238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
    Dobiásová M; Frohlich JJ
    Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LCAT (lecithin:cholesterol acyltransferase)].
    Kinoshita M; Teramoto T
    Rinsho Byori; 2001 Nov; Suppl 116():125-30. PubMed ID: 11797372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCAT- targeted therapies: Progress, failures and future.
    Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.